Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22447219

1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma

Author
CHANG, H1 2 ; QI, X1 2 ; JIANG, A1 ; XU, W3 ; YOUNG, T4 ; REECE, D4
[1] Department of Laboratory Hematology, University Health Network, Toronto, Ontario, Canada
[2] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
[3] Department of Biostatistics, University Health Netmork, Toronto, Ontario, Canada
[4] Department of Medical Oncology and Hematology, University Health Network, Toronto, Ontario, Canada
Source

Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 1, pp 117-121, 5 p ; ref : 21 ref

CODEN
BMTRE9
ISSN
0268-3369
Scientific domain
Medical oncology; Graft, transplantation; Hematology
Publisher
Nature Publishing Group, Basingstoke
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
1p21 FISH multiple myeloma prognosis
Keyword (fr)
Anticancéreux Chimiothérapie Chromosome A1 anormal Complication Cytogénétique Dose forte Délétion Gain génétique Homme Hybridation in situ fluorescence Hématologie Myélome Pronostic Aberration chromosomique Biologie moléculaire Cancer Chromosome anormal Génétique Hémopathie maligne Immunoglobulinopathie Immunopathologie Syndrome lymphoprolifératif Traitement
Keyword (en)
Antineoplastic agent Chemotherapy Abnormal chromosome A1 Complication Cytogenetics High dose Deletion Genetic gain Human Fluorescence in situ hybridization Hematology Myeloma Prognosis Chromosomal aberration Molecular biology Cancer Abnormal chromosome Genetics Malignant hemopathy Immunoglobulinopathy Immunopathology Lymphoproliferative syndrome Treatment
Keyword (es)
Anticanceroso Quimioterapia Cromosoma A1 anormal Complicación Citogenética Dosis fuerte Deleción Ganancia genética Hombre Hibridación in situ fluorescencia Hematología Mieloma Pronóstico Aberración cromosómica Biología molecular Cáncer Cromosoma anormal Genética Hemopatía maligna Inmunoglobulinopatía Inmunopatología Linfoproliferativo síndrome Tratamiento
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B06 Immunopathology / 002B06D Immunodeficiencies. Immunoglobulinopathies / 002B06D02 Immunoglobulinopathies

Discipline
Immunopathology Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
22447219

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web